Latest news
Why Lexicon Pharmaceuticals (LXRX) Is Up 6.9% After Q2 Revenue Collapse And New Shelf Filings - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 00:15:00 GMTLexicon Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $3.86, Implies 57% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:23 GMTLexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:18:43 GMTLexicon Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:03:57 GMTFMR LLC (LXRX) discloses 11.7% Lexicon Pharmaceuticals stake in amended 13G - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 14:32:36 GMTLexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:10 GMTLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:32:50 GMTLexicon Pharma (LXRX) Misses Q2 EPS by 2c - StreetInsiderStreetInsider · Thu, 06 Aug 2026 11:51:16 GMT